fda glp-1 compounding crackdown october 2025 Why the is cracking down on compound drugs for weight loss Compounded weight-loss and hormone drugs
Description
The injection schedule will be tailored to individual needs and the specific GLP-1 medication prescribed, ensuring optimal effectiveness
Marso SP, Daniels GH, BrownFrandsen K, et al
Amylin has become a hot mechanism for weight loss drug developers as companies like Novo, Structure, AstraZeneca and Viking Therapeutics chase after approval of their candidates
doi:10.3389/fpubh.2022.9961
